All coronavirus articles
-
Opinion
Classifications, racial discrimination and Covid-19
Lessons with philosophical significance for how we group people and objects
-
Opinion
Chemists amid coronavirus five years on
Rebecca Trager catches up with four chemists to see how their working lives have changed since the start of the Covid-19 pandemic
-
Opinion
Chemists amid coronavirus five years on: Krystle McLaughlin
An assistant chemistry professor at a small college in New York gets her career back on track, thanks to a tenure clock extension and teaching release
-
Opinion
Chemists amid coronavirus five years on: Anya Gryn’ova
A computational chemist has moved from being group leader at a German research institute to an associate computational chemistry prof in the UK
-
Opinion
Chemists amid coronavirus five years on: Liang Zhang
Lockdown gave a young chemistry professor in China the space and time to consider the most worthwhile projects, and that has benefited his team
-
Opinion
Chemists amid coronavirus five years on: Lee Cronin
A University of Glasgow chemist describes how Covid-19 helped establish the principle of chemputation and spur a chemistry revolution
-
Opinion
Forming bonds through Covid-19
How studying chemistry helped ward off loneliness during the pandemic
-
Business
New Covid-19 antiviral cuts symptoms by 1.5 days
Simnotrelvir already has emergency approval in China
-
Opinion
Setting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
Business
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
Business
Protective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
Business
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
News
UK’s non-profit vaccine manufacturing centre sold off before opening
Pharmaceutical firm Catalent buys government-backed facility near Oxford
-
Business
Moderna sued over Covid-19 vaccine-related patents
Arbutus and Genevant say lipid nanoparticles that protect mRNA infringe six key patents
-
Opinion
Living through Covid-19
Many researchers are now feeling the effects of additional emotional burdens
-
News
Explainer: How do the Covid vaccines measure up against each other and omicron?
Looking at how the evidence stacks up for vaccines against variants and how their performance holds up over time
-
Opinion
The shadow of drug resistance
Why do some medicines stop working, and can we avoid it for Covid-19 antivirals?
-
Careers
The conference conundrum
Following the Covid-19 pandemic, is it time to rethink events for good?
-
Business
Pharmaceuticals roundup 2021
It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry
-
Business
Covid-19 antivirals surge forward
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir